A phase I trial of recombinant tumor necrosis factor (rTNF) administered by continuous intravenous infusion in patients with disseminated malignancy.

Source:http://linkedlifedata.com/resource/pubmed/id/2642024

Download in:

View as

General Info

PMID
2642024